Myocardial ischemia results from the blockade of the coronary arteries caused by atherosclerosis that impairs oxygen delivery. Innate immune and inflammatory pathways have been implicated in myocardial ischemic injury.
TLRs have been identified as the primary innate immune receptors. In the innate immune system, there are receptor proteins that recognize specific patterns (PRRs). These receptors detect pathogen associated molecular patterns (PAMPs). In the first part of this study, we examined whether myocardial TLR4 is involved in the acute myocardial dysfunction caused by septic shock or myocardial ischemia. 
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Cardiac function of TLR4-KO mice improved following MI
In the second part of this study, we tested the hypothesis that TLR4 can be great interest as a therapeutic target against myocardial dysfunction. Reduced myocardial production of interleukins, neutrophil recruitment and inflammatory markers in TLR4-KO mice compared to WT mice.
Increased expression of TLR4 may contribute to the activation of innate immunity in the injured myocardium leading to the depression of cardiac function
Patient with low EF has high TLR4 expression in the blood and heart tissue.
TLR4 can be used as additional biomarkers for HF.
TLR4 has been proven to be of great interest as a therapeutic target against myocardial dysfunction
